Google designs chips as Broadcom AI revenue hits $8.4 billion

Broadcom's artificial intelligence revenue has impressively doubled, now reaching $8.4 billion, solidifying its position as a significant player in the AI hardware sector. The company designs chips for Alphabet, highlighting its crucial role in the AI supply chain. While Nvidia often captures headlines, Broadcom's focus on custom chips presents a compelling investment opportunity, with analysts optimistic about its future performance.

Investment in AI continues to surge, with venture capitalist Nathan Benaich's Air Street Capital raising $230 million for new AI startups. Benaich began investing in AI as early as 2013, predating the widespread popularity of tools like ChatGPT. This new fund marks Air Street Capital as Europe's largest solo VC fund, building on a strong track record of backing successful AI companies such as ElevenLabs and Synthesia.

In the healthcare sector, Verily, with Alphabet as a significant minority investor, secured $300 million in new funding to advance its AI-driven precision health platform. This investment aims to expand partnerships and integrate AI into clinical research and healthcare workflows. Similarly, UnitedHealth Group is increasing its own investment in artificial intelligence to enhance operational efficiency, as detailed at the Barclays Global Healthcare Conference on March 10.

Beyond direct investments, the broader AI market shows varied dynamics. Oracle Japan achieved record sales and profit growth, largely fueled by demand for cloud services and AI, with its cloud segment seeing a 34.8% year-over-year sales increase. Meanwhile, Applied Materials benefits from robust AI demand, providing essential equipment for advanced semiconductor chipmakers. However, fears of AI disrupting traditional software uses led to a decline in software stocks, impacting ETFs like the iShares Expanded Tech-Software Sector ETF.

Regarding AI investment strategies, Gartner advises Chief Financial Officers to reconsider how they evaluate AI initiatives. They suggest treating AI investments as a portfolio of diverse bets, rather than solely focusing on immediate financial return on investment. This approach encourages recognizing non-financial benefits, such as improved decision-making and increased organizational agility.

Key Takeaways

  • Broadcom's AI revenue doubled to $8.4 billion, positioning it as a major AI hardware supplier, including for Alphabet.
  • Venture capitalist Nathan Benaich's Air Street Capital raised $230 million for AI startups, becoming Europe's largest solo VC fund.
  • Verily secured $300 million in new funding, with Alphabet as a significant minority investor, to advance its AI-driven precision health platform.
  • UnitedHealth Group is increasing its investment in artificial intelligence to improve operational efficiency.
  • Oracle Japan achieved record sales and profit growth, driven by high demand for cloud services and AI.
  • Applied Materials benefits from strong demand for AI chips, providing essential equipment for semiconductor manufacturing.
  • Software stocks experienced a decline due to concerns that AI could make some software uses outdated.
  • Gartner advises CFOs to view AI investments as a portfolio, considering non-financial benefits beyond immediate ROI.
  • Nathan Benaich's Air Street Capital invested in AI before the widespread popularity of tools like ChatGPT.

UnitedHealth expands AI use for better efficiency

UnitedHealth Group is increasing its investment in artificial intelligence to improve how it operates. The company shared its plans for growth and innovation at the Barclays Global Healthcare Conference on March 10. Despite some challenges, UnitedHealth is focused on making its business more efficient through new technologies. The company also reaffirmed its financial forecast for the future.

UnitedHealth boosts efficiency with new AI investments

UnitedHealth Group is investing more in artificial intelligence to make its operations more efficient. The company presented its strategy for growth and innovation at the Barclays 28th Annual Global Healthcare Conference on March 10. UnitedHealth highlighted its focus on improvements and innovation, even while facing some difficulties. The company also restated its financial outlook.

Broadcom's AI revenue doubles to $8.4 billion

Broadcom's revenue from artificial intelligence has doubled, reaching $8.4 billion. This rapid growth makes Broadcom a major player in AI hardware and could position it as an overlooked AI stock for 2026. The company designs chips for Alphabet, showing its important role in supplying AI hardware. Its quiet success and fast growth suggest strong future potential for investors interested in AI.

Broadcom AI revenue doubles to $8.4 billion

Broadcom's revenue from artificial intelligence has doubled to $8.4 billion, making it a key player in the AI market. The company is Alphabet's chip design partner, which is a major reason for its success. Analysts are positive about Broadcom's future due to its strong performance and growing share in AI hardware. While Nvidia gets a lot of attention, Broadcom's custom chip focus offers a promising investment opportunity.

Applied Materials stock offers AI opportunity

Chris Versace of Tematica Research suggests that a recent drop in Applied Materials stock might be a good chance to buy. He noted that strong demand for artificial intelligence is benefiting the company. Applied Materials provides essential equipment and services for chipmakers creating advanced semiconductors for AI. Despite the cyclical nature of the semiconductor market, the demand for AI chips is expected to stay strong, positioning Applied Materials well for the future.

AI ETFs show mixed performance in 2026

Three Artificial Intelligence Exchange Traded Funds (ETFs) show different results in 2026. The Invesco AI and Next Gen Software ETF (IGPT) is up 3% year-to-date, focusing on semiconductor hardware. The Roundhill Generative AI & Technology ETF (CHAT) has gained 8% and achieved 77% returns over the past year, with global exposure to AI companies. The JPMorgan U.S. Tech Leaders ETF (JTEK) is down 8% year-to-date, despite holding major tech stocks.

Software stocks drop amid AI disruption fears

Software stocks experienced a decline on Tuesday due to renewed concerns about artificial intelligence potentially making some software uses outdated. The iShares Expanded Tech-Software Sector ETF was affected by this trend. Investors are reassessing the impact of AI on the software industry.

VC raises $230 million for AI startups

Venture capitalist Nathan Benaich has raised $230 million for his fund Air Street Capital to invest in AI startups. Benaich invested in AI before ChatGPT became popular, starting in 2013. His new fund is significantly larger than his previous ones, making Air Street Capital the largest solo VC fund in Europe. He has a strong track record, backing successful AI companies like ElevenLabs and Synthesia.

Oracle Japan sees record growth from cloud and AI

Oracle Japan achieved record sales and profit growth, driven by high demand for cloud services and artificial intelligence. The cloud segment saw a 34.8% increase in sales year-over-year, maintaining a strong operating margin of 32.4%. This growth was particularly strong in the government and small to medium-sized business sectors. The company's performance highlights the increasing adoption of cloud and AI technologies.

CFOs must rethink AI investment returns Gartner

Gartner advises Chief Financial Officers (CFOs) to reconsider how they evaluate investments in artificial intelligence. They suggest that AI investments should be viewed as a portfolio of different types of bets, not just a single return on investment (ROI) problem. CFOs often focus too narrowly on immediate financial gains, overlooking non-financial benefits like better decision-making and increased agility. Gartner recommends treating AI like a portfolio, balancing different types of initiatives and scaling successful ones.

Verily raises $300M for precision health AI strategy

Verily has secured $300 million in new funding, led by Series X Capital, to advance its AI-driven precision health platform. Alphabet is also a significant minority investor in the company. This investment will help Verily expand its partnerships and integrate AI into clinical research and healthcare workflows. The funding will support the scaling of its platform to unify health data and provide more personalized patient care.

Sources

NOTE:

This news brief was generated using AI technology (including, but not limited to, Google Gemini API, Llama, Grok, and Mistral) from aggregated news articles, with minimal to no human editing/review. It is provided for informational purposes only and may contain inaccuracies or biases. This is not financial, investment, or professional advice. If you have any questions or concerns, please verify all information with the linked original articles in the Sources section below.

Artificial Intelligence AI Investment Healthcare AI AI Efficiency AI Hardware AI Revenue Semiconductor Industry AI ETFs Software Stocks AI Startups Venture Capital Cloud Computing Precision Health AI Strategy Financial Forecast Innovation Technology

Comments

Loading...